Addus HomeCare (ADUS) Competitors $104.96 -1.82 (-1.70%) Closing price 08/1/2025 04:00 PM EasternExtended Trading$105.01 +0.05 (+0.05%) As of 08/1/2025 06:08 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock ADUS vs. GH, OPCH, RDNT, BTSG, SHC, SGRY, CON, PRVA, WGS, and PGNYShould you be buying Addus HomeCare stock or one of its competitors? The main competitors of Addus HomeCare include Guardant Health (GH), Option Care Health (OPCH), RadNet (RDNT), BrightSpring Health Services (BTSG), Sotera Health (SHC), Surgery Partners (SGRY), Concentra Group Holdings Parent (CON), Privia Health Group (PRVA), GeneDx (WGS), and Progyny (PGNY). These companies are all part of the "healthcare" industry. Addus HomeCare vs. Its Competitors Guardant Health Option Care Health RadNet BrightSpring Health Services Sotera Health Surgery Partners Concentra Group Holdings Parent Privia Health Group GeneDx Progyny Guardant Health (NASDAQ:GH) and Addus HomeCare (NASDAQ:ADUS) are both medical companies, but which is the better stock? We will compare the two businesses based on the strength of their profitability, dividends, institutional ownership, risk, valuation, media sentiment, earnings and analyst recommendations. Which has more volatility & risk, GH or ADUS? Guardant Health has a beta of 1.43, meaning that its share price is 43% more volatile than the S&P 500. Comparatively, Addus HomeCare has a beta of 0.8, meaning that its share price is 20% less volatile than the S&P 500. Which has better valuation & earnings, GH or ADUS? Addus HomeCare has higher revenue and earnings than Guardant Health. Guardant Health is trading at a lower price-to-earnings ratio than Addus HomeCare, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioGuardant Health$739.02M6.99-$436.37M-$3.35-12.36Addus HomeCare$1.15B1.67$73.60M$4.4323.69 Do institutionals & insiders believe in GH or ADUS? 92.6% of Guardant Health shares are held by institutional investors. Comparatively, 95.4% of Addus HomeCare shares are held by institutional investors. 6.1% of Guardant Health shares are held by insiders. Comparatively, 4.6% of Addus HomeCare shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term. Does the media prefer GH or ADUS? In the previous week, Guardant Health had 19 more articles in the media than Addus HomeCare. MarketBeat recorded 25 mentions for Guardant Health and 6 mentions for Addus HomeCare. Addus HomeCare's average media sentiment score of 1.15 beat Guardant Health's score of 0.79 indicating that Addus HomeCare is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Guardant Health 10 Very Positive mention(s) 2 Positive mention(s) 9 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Addus HomeCare 4 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do analysts prefer GH or ADUS? Guardant Health presently has a consensus target price of $54.95, indicating a potential upside of 32.66%. Addus HomeCare has a consensus target price of $142.57, indicating a potential upside of 35.83%. Given Addus HomeCare's stronger consensus rating and higher probable upside, analysts clearly believe Addus HomeCare is more favorable than Guardant Health.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Guardant Health 0 Sell rating(s) 0 Hold rating(s) 19 Buy rating(s) 1 Strong Buy rating(s) 3.05Addus HomeCare 0 Sell rating(s) 0 Hold rating(s) 6 Buy rating(s) 2 Strong Buy rating(s) 3.25 Is GH or ADUS more profitable? Addus HomeCare has a net margin of 6.52% compared to Guardant Health's net margin of -49.93%. Addus HomeCare's return on equity of 9.23% beat Guardant Health's return on equity.Company Net Margins Return on Equity Return on Assets Guardant Health-49.93% N/A -28.95% Addus HomeCare 6.52%9.23%6.96% SummaryAddus HomeCare beats Guardant Health on 12 of the 17 factors compared between the two stocks. Get Addus HomeCare News Delivered to You Automatically Sign up to receive the latest news and ratings for ADUS and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding ADUS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ADUS vs. The Competition Export to ExcelMetricAddus HomeCareMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.96B$3.69B$5.47B$9.53BDividend YieldN/A1.37%4.74%4.08%P/E Ratio23.6933.3928.6723.80Price / Sales1.67151.02422.3188.12Price / Cash19.8121.3835.4557.96Price / Book1.964.218.275.55Net Income$73.60M$189.47M$3.24B$259.03M7 Day Performance-4.08%-5.30%-3.63%-4.56%1 Month Performance-4.90%-6.08%4.40%4.49%1 Year Performance-12.77%-0.58%25.97%18.05% Addus HomeCare Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ADUSAddus HomeCare4.9161 of 5 stars$104.96-1.7%$142.57+35.8%-13.9%$1.96B$1.15B23.6949,703Positive NewsUpcoming EarningsGHGuardant Health4.5629 of 5 stars$44.27-0.3%$54.45+23.0%+24.2%$5.50B$739.02M0.002,021Trending NewsEarnings ReportAnalyst ForecastOPCHOption Care Health4.6309 of 5 stars$29.77+0.3%$35.50+19.2%-8.2%$4.86B$5.00B21.678,088News CoveragePositive NewsEarnings ReportAnalyst ForecastRDNTRadNet4.0535 of 5 stars$57.83+0.7%$69.60+20.4%-5.7%$4.31B$1.83B-134.4911,021Positive NewsBTSGBrightSpring Health Services2.723 of 5 stars$20.48-0.2%$24.90+21.6%+60.6%$3.61B$11.27B33.1135,000News CoverageEarnings ReportGap DownSHCSotera Health2.4195 of 5 stars$12.29-0.1%$16.00+30.2%-18.2%$3.49B$1.10B19.843,000Positive NewsUpcoming EarningsSGRYSurgery Partners2.7453 of 5 stars$22.44+5.6%$33.33+48.5%-29.6%$2.72B$3.11B35.4315,000Positive NewsUpcoming EarningsGap UpCONConcentra Group Holdings Parent2.8496 of 5 stars$20.05+2.0%$28.50+42.1%-14.0%$2.52B$1.90B14.5611,250Upcoming EarningsPRVAPrivia Health Group3.7891 of 5 stars$19.70-0.1%$28.38+44.1%-8.0%$2.40B$1.74B164.181,140Upcoming EarningsWGSGeneDx2.8179 of 5 stars$84.91+6.4%$92.33+8.7%+215.0%$2.28B$305.45M87.721,200Earnings ReportAnalyst ForecastInsider TradeOptions VolumeGap DownHigh Trading VolumePGNYProgyny2.0137 of 5 stars$23.20+0.4%$24.82+7.0%-17.0%$1.98B$1.17B43.60310Positive NewsUpcoming Earnings Related Companies and Tools Related Companies Guardant Health Alternatives Option Care Health Alternatives RadNet Alternatives BrightSpring Health Services Alternatives Sotera Health Alternatives Surgery Partners Alternatives Concentra Group Holdings Parent Alternatives Privia Health Group Alternatives GeneDx Alternatives Progyny Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:ADUS) was last updated on 8/2/2025 by MarketBeat.com Staff From Our PartnersBuffett to put 90% of his money in this one stock?CPA and CFA says you have WAY too many stocks - just buy these 3 After years working at the biggest accoun...Altimetry | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredOne stock to replace NvidiaI'm a Futurist: Here are 3 stocks better than Nvidia Nvidia's own customers could soon become fierce compet...InvestorPlace | SponsoredCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | SponsoredJeff Bezos Launches "ChatGPT Killer"?Amazon just launched Nova—its secretive new AI system designed to rival ChatGPT. Bezos says he now spends 95% ...Stansberry Research | SponsoredAlien rocks potentially worth trillions…It might look like just a weird rock—but it’s tied to a discovery 60 Minutes says could be worth up to $16 tri...Porter & Company | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredToo busy to trade? Good.Too busy to trade? That might be your edge. This after-hours strategy is built for people who don’t sit at ...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Addus HomeCare Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share Addus HomeCare With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ADUS Stock Alerts